Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: The multinational randomized LeoDOR trial.
Pölzl G, Altenberger J, Comín-Colet J, Delgado JF, Fedele F, García-González MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Maier S, Vrtovec B, Wikström G, Zima E, Bauer A; LeoDOR Investigators.
Pölzl G, et al. Among authors: fedele f.
Eur J Heart Fail. 2023 Nov;25(11):2007-2017. doi: 10.1002/ejhf.3006. Epub 2023 Sep 4.
Eur J Heart Fail. 2023.
PMID: 37634941
Free article.
Clinical Trial.